NOTV - Inotiv Inc

Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. The company is headquartered in West Lafayette, Indiana.

52W High

$6.48

52W Low

$1.15

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

4.17

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

23.51

EV/Revenue (<3 favorable)

0.99

P/S (TTM) (<3 favorable)

0.11

P/B (<3 favorable)

0.39

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

11.30%

Institutions (25–75% balanced)

25.43%

Shares Outstanding

34,355,300

Float

31,212,200

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

505,299,000

Gross Profit (TTM)

117,890,000

EPS (TTM)

-2.62

Profit Margin (>10% good)

-0.16%

Operating Margin (TTM) (higher better)

-0.04%

ROE (TTM) (>15% strong)

-0.49%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

0.24

Momentum

Bearish momentum

Value

-0.1495

-0.1422

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025